Medicine, which was developed by the American company Pfizer, can be 89 percent to reduce the risks of hospitalization or lethal exodus after the changed COVID-19. This became known on the basis of the study of the drug, reported on the company’s website.
It is clarified that 1.2 thousand sick COVID-19 participated in the studies, in which the disease could develop on an unfavorable scenario.
A number of volunteers as part of the study received placebo. It turned out that the probability of hospitalization among those who took this drug was much less compared to those who received placebo. In addition, none of those who took the medicine did not die. Among those who took placebo, ten patients died.
Pfizer Executive Director Albert Burla clarified that the medicine will help to avoid nine out of ten hospitalizations in the case of COVID-19 infection.
Earlier, the European Medicine Agency (EMA) responded to information on violation of the Vaccine test from the coronavirus company Pfizer. They added that on this issue interact intensively with USA control and drug control.